Chattopadhyay N
No ORCID on file
· 1 paper in corpus
nonrandomized-trial
2019
AIMS: The study objective was to evaluate the pharmacokinetics of the selective progesterone receptor modulator vilaprisan in participants with hepatic impairment. Additionally, the safety and tolerability of vilaprisan were investigated. …